A look at the role of chromatography in the fight against illegal food products entering the food chain.
winyu/stock.adobe.com
Estimated losses due to counterfeit and illegal products in the agricultural and pharmaceutical industries comprise a staggering 10% of global trade, and for some nations like Brazil it is believed to be closer to 20% (1,2). The impact of counterfeit and illegal material goes far beyond the loss of sales, however, extending into brand integrity damage and trademark dilution as well as the high cost of enforcing intellectual property rights and protection. In agriculture, residual effects of counterfeit products that are introduced into our food chain, if not manufactured correctly or used according to the registered specifications, have the potential to affect the environment as well as the health and well-being of consumers.
Legitimate commercial pharmaceutical and agricultural producers, after many years of work to prove the safety of their products, submit analytical methods for the identification and quantitation of technical active ingredients and full formulations to regulatory agencies worldwide. These methods, referred to as enforcement methods, verify that products sold meet the registered labelled specifications. Specifically, these methods are used to determine the identity and amount of the active ingredient or ingredients that are present.
Regulatory agencies can use these individual product enforcement methods to bring legal action when suspect samples are found. A suspect product can be defined as any of the following: a product purposely manufactured to mimic a registered and trademarked material under patent, a product purposely sold in a container to mimic a registered product’s container and label, a product purposely sold under an accepted tradename but containing another product, a product purposely sold under an accepted tradename with no active ingredient present, or a product sold with an incorrect active ingredient present.
Most suspect samples found and believed to be from counterfeit suppliers and illegal sources are formulated products. As such, the active ingredient is just a portion of the components making up the marketed product, with the percentage of active ingredient ranging from as low as 0.2% to as high as 75–80%, depending on the strength of the active ingredient and the registered use of the formulated product. The rest of the ingredients are coformulating agents. These coformulants are a variety of materials, including but not limited to dispersants, biocides, binders, dyes, stabilizers, emulsifiers, adjuvants, wetting agents, antifoams, clays, gums, flow aids, and diluents. Basically, the coformulants are a broad array of chemical substances with varying physical properties to help the active ingredient reach the target portion of an organism. Original recipes of formulations are considered confidential information by the registered manufacturers and by regulatory authorities in most countries. As a result, it is difficult for the counterfeiters and illegal manufacturers to match the original formulations, particularly if the original formulations are complex and expensive. Consequently, counterfeit and illegal samples likely will have not only variability of the active ingredient but also differences in coformulant ingredients. Simply, this means counterfeit and illegal products could contain the same coformulants as the original product but most likely will not. The coformulants will probably be from different sources, in varying amounts or ratios, or both, than what was original to the registered product. Such differences in coformulants can also affect the efficacy and safety of the product.
Enforcement methods are typically based on liquid or gas chromatography (LC or GC) and are part of the arsenal of analytical tools used to verify that products are authentic. These methods are validated under good laboratory practice (GLP) guidelines and thus undergo standard validation parameters required to ascertain the rigour of the measurement, including the precision, accuracy (recovery), linearity, and specificity of the active ingredient.
When a counterfeit or illegal suspect sample is tested for its authenticity, the most straightforward and uncomplicated test is active ingredient identification. A chromatographic retention time confirmation is a quick screen to start this identification. Even with more than 1055 active pesticide ingredients authorized for use in the United States alone, which yield more than 20 000 marketed products, chromatography can positively eliminate the majority of those present (3,4). Then, if necessary, a confirmation conducted with UV spectroscopy or mass spectrometry (MS) can provide definitive identification. In clear‑cut cases where chromatography is used as a screening technique, one can readily determine if a product has an incorrect active ingredient present, no active ingredient at all, or several active ingredients instead of one, and the appropriate response can be taken, even without further confirmatory techniques.
As the complexity of suspect samples increases, separation methods in combination with advanced confirmatory techniques are needed to determine the exact sources of material, whether authentic, generic, counterfeit, or illegal. Upfront, the challenge is often to determine how much analytical data should be required to prove inauthenticity, which is vital to stopping this rampant criminal activity. Chromatographic techniques are key technologies to not only solve some of these challenging problems but also to determine how much further work may be required.
References
Mary Ellen P. McNally, PhD, is a Global R&D Fellow at the Stine Research Center for FMC Corporation, Pennsylvania, USA. Her specialties include separations and method development using liquid chromatography, gas chromatography, and supercritical fluid chromatography; sample preparation focused on agricultural products; and ultratrace level analysis and detection. She was employed by DuPont for 33 years before joining FMC, receiving awards including DuPont Crop Protection’s Scientific Leadership Award
E-mail: Mary-Ellen.McNally@fmc.com
Website: www.fmc.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.